As discussed previously, Cldn18 is specifically expressed in gastric epithelial cells and represents a novel therapeutic target in human gastric cancer, making this an appropriate driver for gastric-specific genetic manipulation (Tojjari et al., 2024). Here, CLDN18 is linked to gastric cancer.